Oral Wegovy: how the semaglutide pill works and what to track

Introduction

Oral Wegovy is a once-daily semaglutide tablet for eligible adults using the product for approved cardiovascular-risk reduction or weight-management indications. The tablet must be taken in the morning on an empty stomach with no more than 4 ounces of water, followed by a wait of at least 30 minutes. The current FDA label is the source for the dose steps and administration rules.

How the pill differs from the Wegovy injection

The oral tablet and injection both contain semaglutide, but they create different routines. Oral Wegovy is taken every morning and has strict food, water, and oral-medication timing instructions. Injectable Wegovy is taken once weekly and can be administered at any time of day, with or without meals, under its injection instructions.

Do not use the tablet and injection together or switch between them by estimating an equivalent dose. The FDA label contains specific switching recommendations, and your prescriber should decide whether a switch is appropriate.

The 30-minute morning window matters

Take the tablet with plain water only, using no more than 4 ounces. Then wait at least 30 minutes before eating, drinking other beverages, or taking other oral medications. A consistent routine can make this easier: take the tablet at the same time, start a timer, and prepare breakfast after the timer ends.

If you miss an oral Wegovy dose, the label says to skip the missed dose and take the next dose the following day. Do not take extra tablets to compensate. Ask your provider what to do after multiple missed doses.

Oral Wegovy dose steps are taken daily

The FDA label starts oral Wegovy at 1.5 mg once daily for 30 days. The labeled escalation then moves to 4 mg for days 31 through 60, 9 mg for days 61 through 90, and 25 mg as the recommended maintenance dose from day 91 onward. If a dose is not tolerated, the label allows consideration of delaying escalation.

These steps are a medication-label summary, not an individualized prescription. Your clinician may change the plan based on indication, tolerability, other medicines, and health history.

What to track when starting or switching

Use a simple daily record for the first several months:

• Tablet time and fasting timer: Record when the dose was taken and when the 30-minute window ended.
• Other oral medicines: Note whether any routine could interfere with the required timing.
• Symptoms: Track nausea, vomiting, constipation, diarrhea, abdominal pain, fatigue, appetite, and other changes.
• Weight and nutrition: Review trends over time, not one reading.
• Dose step: Mark every escalation so a symptom pattern has context.

Track oral Wegovy with Shotsy

Shotsy supports oral Wegovy dose logging, reminders, a fasting timer, side-effect tracking, weight charts, and estimated semaglutide-level charts. The estimated chart is not a blood measurement and should not be used to make dose decisions. It is a way to organize timing and trends for a conversation with your healthcare provider.

If you switch between oral Wegovy and injectable Wegovy, or move to another medication such as Foundayo, keep the historical record and ask your prescriber how the transition should be scheduled.

Conclusion

Oral Wegovy can fit people who prefer a daily tablet, but its morning fasting routine is part of the treatment. Track the tablet time, 30-minute window, dose step, symptoms, appetite, and weight trend. Use the current FDA label and your prescriber’s instructions when starting, switching, missing doses, or changing treatment.

For related reading, see the Foundayo guide, medication switching guide, and GLP‑1 side-effects overview.